Pfizer Won't Get To Trim BYU's Bextra-Celebrex Suit

Law360, New York (March 13, 2012, 7:34 PM EDT) -- A Utah federal judge on Tuesday declined to rule on two claims in a contract and trade secrets suit brought against Pfizer Inc. by Brigham Young University and a professor who claims he discovered an enzyme that led to the development of the anti-inflammatory drugs Bextra and Celebrex.

Pfizer had asked the court to grant summary judgment on BYU's claims that Pfizer breached two parts of a research agreement originally signed by the University and co-defendant Monsanto Co., the pharmaceutical wing of which is now under...
To view the full article, register now.